168 related articles for article (PubMed ID: 7487210)
1. Clinical behavior and prognostic factors of periampullary adenocarcinoma.
Chan C; Herrera MF; de la Garza L; Quintanilla-Martinez L; Vargas-Vorackova F; Richaud-Patín Y; Llorente L; Uscanga L; Robles-Diaz G; Leon E
Ann Surg; 1995 Nov; 222(5):632-7. PubMed ID: 7487210
[TBL] [Abstract][Full Text] [Related]
2. Factors predictive of survival in ampullary carcinoma.
Howe JR; Klimstra DS; Moccia RD; Conlon KC; Brennan MF
Ann Surg; 1998 Jul; 228(1):87-94. PubMed ID: 9671071
[TBL] [Abstract][Full Text] [Related]
3. Carcinoma of the ampulla of Vater: factors influencing long-term survival of 127 patients with resection.
Qiao QL; Zhao YG; Ye ML; Yang YM; Zhao JX; Huang YT; Wan YL
World J Surg; 2007 Jan; 31(1):137-43; discussion 144-6. PubMed ID: 17171495
[TBL] [Abstract][Full Text] [Related]
4. Predictors of survival in periampullary cancers following pancreaticoduodenectomy.
Hatzaras I; George N; Muscarella P; Melvin WS; Ellison EC; Bloomston M
Ann Surg Oncol; 2010 Apr; 17(4):991-7. PubMed ID: 20108122
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D1 and bax influence the prognosis after pancreatoduodenectomy for periampullary adenocarcinoma.
Tomazic A; Pegan V; Ferlan-Marolt K; Pleskovic A; Luzar B
Hepatogastroenterology; 2004; 51(60):1832-7. PubMed ID: 15532837
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological Stratification and Long-term Follow-up of Patients with Periampullary Carcinomas.
Schmuck RB; Brokat C; Andreou A; Felsenstein M; Klein F; Sinn B; Pratschke J; Bahra M
Anticancer Res; 2018 Sep; 38(9):5379-5386. PubMed ID: 30194192
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
[TBL] [Abstract][Full Text] [Related]
8. Periampullary adenocarcinoma: analysis of 5-year survivors.
Yeo CJ; Sohn TA; Cameron JL; Hruban RH; Lillemoe KD; Pitt HA
Ann Surg; 1998 Jun; 227(6):821-31. PubMed ID: 9637545
[TBL] [Abstract][Full Text] [Related]
9. An audit of outcomes of a series of periampullary carcinomas.
Berberat PO; Künzli BM; Gulbinas A; Ramanauskas T; Kleeff J; Müller MW; Wagner M; Friess H; Büchler MW
Eur J Surg Oncol; 2009 Feb; 35(2):187-91. PubMed ID: 18343082
[TBL] [Abstract][Full Text] [Related]
10. Recurrent disease after microscopically radical (R0) resection of periampullary adenocarcinoma in patients without adjuvant therapy.
de Castro SM; Kuhlmann KF; van Heek NT; Busch OR; Offerhaus GJ; van Gulik TM; Obertop H; Gouma DJ
J Gastrointest Surg; 2004 Nov; 8(7):775-84; discussion 784. PubMed ID: 15531230
[TBL] [Abstract][Full Text] [Related]
11. [The curative surgery of periampullary tumors. The results of 48 resections].
de Almeida JC; Bettencourt A; Costa CS; de Almeida JM
Acta Med Port; 1995 Jun; 8 Suppl 1():S35-9. PubMed ID: 7653304
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Outcomes and Prognostic Factors in Periampullary Carcinoma.
Sunil BJ; Seshadri RA; Gouthaman S; Ranganathan R
J Gastrointest Cancer; 2017 Mar; 48(1):13-19. PubMed ID: 27484980
[TBL] [Abstract][Full Text] [Related]
13. Association of Histopathologic Phenotype of Periampullary Adenocarcinomas With Survival.
Williams JL; Chan CK; Toste PA; Elliott IA; Vasquez CR; Sunjaya DB; Swanson EA; Koo J; Hines OJ; Reber HA; Dawson DW; Donahue TR
JAMA Surg; 2017 Jan; 152(1):82-88. PubMed ID: 27732711
[TBL] [Abstract][Full Text] [Related]
14. Influence of site of origin and mucin production on survival in ampullary carcinoma.
Dawson PJ; Connolly MM
Ann Surg; 1989 Aug; 210(2):173-9. PubMed ID: 2757420
[TBL] [Abstract][Full Text] [Related]
15. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?
Westgaard A; Pomianowska E; Clausen OP; Gladhaug IP
Ann Surg Oncol; 2013 Feb; 20(2):430-9. PubMed ID: 22956064
[TBL] [Abstract][Full Text] [Related]
16. Intestinal-type of differentiation predicts favourable overall survival: confirmatory clinicopathological analysis of 198 periampullary adenocarcinomas of pancreatic, biliary, ampullary and duodenal origin.
Bronsert P; Kohler I; Werner M; Makowiec F; Kuesters S; Hoeppner J; Hopt UT; Keck T; Bausch D; Wellner UF
BMC Cancer; 2013 Sep; 13():428. PubMed ID: 24053229
[TBL] [Abstract][Full Text] [Related]
17. Non-pancreatic periampullary adenocarcinomas: an explanation for favorable prognosis.
Katz MH; Bouvet M; Al-Refaie W; Gilpin EA; Moossa AR
Hepatogastroenterology; 2004; 51(57):842-6. PubMed ID: 15143931
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of prognosis-associated factors in pancreatic head and peri-ampullary cancer].
Roder JD; Siewert JR
Chirurg; 1992 May; 63(5):410-5. PubMed ID: 1376655
[TBL] [Abstract][Full Text] [Related]
19. Reexploration for periampullary carcinoma: resectability, perioperative results, pathology, and long-term outcome.
Sohn TA; Lillemoe KD; Cameron JL; Pitt HA; Huang JJ; Hruban RH; Yeo CJ
Ann Surg; 1999 Mar; 229(3):393-400. PubMed ID: 10077052
[TBL] [Abstract][Full Text] [Related]
20. [Periampullary carcinoma or tumor of the ampulla of Vater?].
Vasilescu C; Herlea V; Stoicescu M
Chirurgia (Bucur); 2000; 95(5):401-6. PubMed ID: 14870549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
